TABLE 1

Molecular markers

MarkeraCytological locationGenetic locationbGel conditionc
AF0471801B1-B141-0.0I
DMU566614F1-F21-9.0I
G006308B5-B81-17.7I
DROSEV10A1-A21-24.4I
DMTENA11A6-A91-28.4I
DMU1877413D1-33.9II
DMTROPONI16F3-F61-41.4I
DROPASSOV19E31-50.7II
DROEXPAND21C42-0.0I
DROYANETSB22D1-D22-4.1I
AC00573224D1-D22-9.5II
DROGPDHA26A12-21.6I
AC00555529A5-B42-31.4I
G41033E9-E102-44.5I
DRODORSAL36C2-54.3I
AC00475938E1-E92-64.0I
DROGPAD47A2-72.8I
DMMP2049F9-F132-80.8I
AC00424852D2-D152-89.3I
DS0036154B1-B22-93.1I
DSO8687a57C5-D12-102.4I
AC00436558A4-B12-107.6I
DS0801159A1-B22-111.9I
DMRHOb62A1-A33-0I
AC00465863D2-E13-6.5I
DRODSRC64B3-16.5I
DMU1439565D1-D33-28.3I
DROLAMB2Ad67C3-37.9II
DM22F11T73A1-B73-55.2II
DMCATHPO75D43-60.4I
AE001573843-69.4I
DRONANOS91E-F3-77.8I
DMEHAB90B1-B23-84.4I
AC00641489A1-A53-94.7I
DMTRXIII88B33-100.3I
DROPROSA86E33-107.1I
DMTF12595C6-C83-119.7I
DMU4309099D6-D93-132.8I
  • a For accession numbers and primer sequences see Colson et al. (1999).

  • b Genetic map positions inferred from the progeny of simulans-sechellia F1 hybrid females.

  • c I, 4.25% acrylamide gel; II, 2% agarose gel.

  • d sim 132-positive forward primer, CTG GGA ATC TAT CAA TTA; sec S-9-positive forward primer, CTG GGA ATC TAT CAA TTG; common reverse primer, AAT TTG CAG TTG ATA GGC AGC.